Financial Performance
5Y price score: (29)
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 231.8%
US$ Per
Share
By default your notes are visible only to you.
180.2
52-week range
293.8
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
6 %
Dividend Yield TTM
1.2 %
Market cap $
$ 28,865
Price / Earnings TTM
19.2
Price / Book TTM
4.5
PEG TTM
0.5
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
(21.6) %
(17.8) %
231.8 %
Free cash flow per share growth
29.4 %
135.9 %
417.1 %
Earnings per share growth
37.4 %
122.7 %
285 %
Business Summary:
Latest Earnings Call Takeaways
Annual Reports, Presentations And IR Contacts
Go to the websiteResMed — Financial Overview, Stock Price, Market Cap
ResMed is a company. Founded in 1989. As of July 20, 2026, the company's market capitalization is $28864769852 with a current stock price of $198.99.
